Earlier this year, a group of OCD experts and specialists published guidelines on managing OCD during COVID-19. It was quickly becoming evident that traditional exposure and response prevention (ERP) was going to be very difficult to deliver during a pandemic. We present some information on how the AIS has adapted to delivery of treatment during the coronavirus pandemic.
It is fairly well known that people with OCD have symptoms for a long time before seeking help, and wait longer before receiving effective treatment. In light of a new study from Brazil about the speed of development of OCD symptoms (Thompson et al, 2020), I review the evidence that highlights these delays.